{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:54Z","timestamp":1792785054673,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Young Scientists Fund Project of Henan Provincial Natural Science Foundation","award":["252300423899"],"award-info":[{"award-number":["252300423899"]}]},{"name":"Joint Construction Project of Henan Medical Science and Technology Foundation","award":["LHGJ20240286"],"award-info":[{"award-number":["LHGJ20240286"]}]},{"name":"the Science and Technology Research Project of Henan Province","award":["252102310213"],"award-info":[{"award-number":["252102310213"]}]},{"name":"the Key Scientific Research Project of Higher Education Institutions of Henan Province","award":["26A320014"],"award-info":[{"award-number":["26A320014"]}]},{"name":"National Natural Science Foundation of China","award":["82470807"],"award-info":[{"award-number":["82470807"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61910-y","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:26:23Z","timestamp":1784629583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A retrospective study of intravesical botulin toxin type A in children with refractory detrusor overactivity"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaokai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"7","key":"61910_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S2352-4642(19)30113-0","volume":"3","author":"AJ Nieuwhof-Leppink","year":"2019","unstructured":"Nieuwhof-Leppink, A. J. et al. Daytime urinary incontinence in children and adolescents. Lancet Child Adolesc. Health 3(7), 492\u2013501 (2019).","journal-title":"Lancet Child Adolesc. Health"},{"issue":"4","key":"61910_CR2","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.eururo.2017.12.031","volume":"73","author":"AK Nambiar","year":"2018","unstructured":"Nambiar, A. K. et al. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur. Urol. 73(4), 596\u2013609 (2018).","journal-title":"Eur. Urol."},{"key":"61910_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/17562872251315927","volume":"17","author":"T Fay","year":"2025","unstructured":"Fay, T. et al. Paediatric urodynamic studies: Emerging technologies and new frontiers. Ther. Adv. Urol. 17, 17562872251315927 (2025).","journal-title":"Ther. Adv. Urol."},{"issue":"1","key":"61910_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/iju.12008","volume":"20","author":"O Yamaguchi","year":"2013","unstructured":"Yamaguchi, O. Latest treatment for lower urinary tract dysfunction: Therapeutic agents and mechanism of action. Int. J. Urol. 20(1), 28\u201339 (2013).","journal-title":"Int. J. Urol."},{"key":"61910_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/toxins16080339","author":"A Zulli","year":"2024","unstructured":"Zulli, A. et al. Intravesical botulin toxin-A injections for neurogenic bladder dysfunction in children: Summary update on last 10 years of research. Toxins https:\/\/doi.org\/10.3390\/toxins16080339 (2024).","journal-title":"Toxins"},{"key":"61910_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14070498","author":"HC Kuo","year":"2022","unstructured":"Kuo, H. C. Clinical application of botulinum neurotoxin in lower-urinary-tract diseases and dysfunctions: Where are we now and what more can we do?. Toxins https:\/\/doi.org\/10.3390\/toxins14070498 (2022).","journal-title":"Toxins"},{"issue":"2","key":"61910_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.pmrj.2018.07.016","volume":"11","author":"LF Cooley","year":"2019","unstructured":"Cooley, L. F. & Kielb, S. A review of botulinum toxin A for the treatment of neurogenic bladder. PM R 11(2), 192\u2013200 (2019).","journal-title":"PM R"},{"issue":"6","key":"61910_CR8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","volume":"75","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet, B. et al. A comprehensive review of overactive bladder pathophysiology: On the way to tailored treatment. Eur. Urol. 75(6), 988\u20131000 (2019).","journal-title":"Eur. Urol."},{"issue":"6","key":"61910_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/ans.19309","volume":"95","author":"G He","year":"2025","unstructured":"He, G., Shen, N. & Feng, S. Botulinum toxin A for the treatment of neurogenic bladder in children: A systematic review and meta-analysis. ANZ J. Surg. 95(6), 1115\u20131121 (2025).","journal-title":"ANZ J. Surg."},{"key":"61910_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.urology.2017.09.005","volume":"111","author":"CA Sekerci","year":"2018","unstructured":"Sekerci, C. A. et al. Clinical and urodynamic results of repeated intradetrusor onabotulinum toxin A injections in refractory neurogenic detrusor overactivity: Up to 5 injections in a cohort of children with myelodysplasia. Urology 111, 168\u2013175 (2018).","journal-title":"Urology"},{"key":"61910_CR11","doi-asserted-by":"publisher","first-page":"1407009","DOI":"10.3389\/fped.2024.1407009","volume":"12","author":"BT Frainey","year":"2024","unstructured":"Frainey, B. T. & Clayton, D. B. OnabotulinumtoxinA is now an important tool for managing pediatric neurogenic lower urinary tract dysfunction. Front. Pediatr. 12, 1407009 (2024).","journal-title":"Front. Pediatr."},{"issue":"3","key":"61910_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/JU.0000000000000309","volume":"202","author":"DJ Lightner","year":"2019","unstructured":"Lightner, D. J. et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline amendment 2019. J. Urol. 202(3), 558\u2013563 (2019).","journal-title":"J. Urol."},{"issue":"9","key":"61910_CR13","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.jpedsurg.2014.04.004","volume":"49","author":"P L\u00e9on","year":"2014","unstructured":"L\u00e9on, P. et al. Botulinum toxin injections in the management of non-neurogenic overactive bladders in children. J. Pediatr. Surg. 49(9), 1424\u20131428 (2014).","journal-title":"J. Pediatr. Surg."},{"issue":"3","key":"61910_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jpedsurg.2018.05.012","volume":"54","author":"GM Al Edwan","year":"2019","unstructured":"Al Edwan, G. M. et al. Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: A preliminary report. J. Pediatr. Surg. 54(3), 595\u2013599 (2019).","journal-title":"J. Pediatr. Surg."},{"issue":"4","key":"61910_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/nau.22751","volume":"35","author":"PF Austin","year":"2016","unstructured":"Austin, P. F. et al. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the international children\u2019s continence society. Neurourol. Urodyn. 35(4), 471\u2013481 (2016).","journal-title":"Neurourol. Urodyn."},{"issue":"1","key":"61910_CR16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41598-020-79974-9","volume":"11","author":"F Sawaqed","year":"2021","unstructured":"Sawaqed, F. & Suoub, M. Validating 7-items overactive bladder symptom score (OABSS) through Arabic linguistic version. Sci. Rep. 11(1), 661 (2021).","journal-title":"Sci. Rep."},{"issue":"12","key":"61910_CR17","volume":"16","author":"H Mahfoudi","year":"2024","unstructured":"Mahfoudi, H. et al. Determinants of quality of life in patients with urinary incontinence: An assessment using the incontinence quality of life (I-QOL) scale. Cureus 16(12), e76673 (2024).","journal-title":"Cureus"},{"issue":"6","key":"61910_CR18","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.juro.2014.01.110","volume":"191","author":"PF Austin","year":"2014","unstructured":"Austin, P. F. et al. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the international children\u2019s continence society. J. Urol. 191(6), 1863-1865.e13 (2014).","journal-title":"J. Urol."},{"key":"61910_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/toxins17040202","author":"CK Hsu","year":"2025","unstructured":"Hsu, C. K. et al. Efficacy and predictive factors of intravesical botulinum toxin A injection for treating neurogenic detrusor overactivity in children: A single-center retrospective study. Toxins https:\/\/doi.org\/10.3390\/toxins17040202 (2025).","journal-title":"Toxins"},{"issue":"6","key":"61910_CR20","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.urology.2014.09.001","volume":"84","author":"SW Kim","year":"2014","unstructured":"Kim, S. W. et al. Preoperative urodynamic factors predicting outcome of botulinum toxin-A intradetrusor injection in children with neurogenic detrusor overactivity. Urology 84(6), 1480\u20131484 (2014).","journal-title":"Urology"},{"issue":"4","key":"61910_CR21","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.urology.2011.06.020","volume":"78","author":"M Gotoh","year":"2011","unstructured":"Gotoh, M. et al. Responsiveness and minimal clinically important change in overactive bladder symptom score. Urology 78(4), 768\u2013773 (2011).","journal-title":"Urology"},{"issue":"3","key":"61910_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/nau.20744","volume":"29","author":"I Yalcin","year":"2010","unstructured":"Yalcin, I. et al. Reductions in stress urinary incontinence episodes: What is clinically important for women?. Neurourol. Urodyn. 29(3), 344\u2013347 (2010).","journal-title":"Neurourol. Urodyn."},{"issue":"8","key":"61910_CR23","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/nau.25580","volume":"43","author":"Y Ventura","year":"2024","unstructured":"Ventura, Y. et al. Success rate and predicting factors for repeated high-dose intradetrusor dysport injections in children with neurogenic bladder: A retrospective study. Neurourol. Urodyn. 43(8), 2140\u20132146 (2024).","journal-title":"Neurourol. Urodyn."},{"issue":"5-6","key":"61910_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00702-022-02494-5","volume":"129","author":"D Dressler","year":"2022","unstructured":"Dressler, D. & Johnson, E. A. Botulinum toxin therapy: Past, present and future developments. J. Neural Transm. 129(5\u20136), 829\u2013833 (2022).","journal-title":"J. Neural Transm."},{"issue":"2","key":"61910_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/CU9.0000000000000272","volume":"19","author":"Y Zhou","year":"2025","unstructured":"Zhou, Y. et al. Advancements in the management of overactive bladder in women using nano-botulinum toxin type A: A narrative review. Curr. Urol. 19(2), 77\u201383 (2025).","journal-title":"Curr. Urol."},{"issue":"3","key":"61910_CR26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/nau.24879","volume":"41","author":"JC Truzzi","year":"2022","unstructured":"Truzzi, J. C. et al. Botulinum toxin for treating overactive bladder in men: A systematic review. Neurourol. Urodyn. 41(3), 710\u2013723 (2022).","journal-title":"Neurourol. Urodyn."},{"issue":"Suppl 3","key":"61910_CR27","first-page":"S104","volume":"39","author":"S Malde","year":"2020","unstructured":"Malde, S. et al. Botulinum toxin A for refractory OAB and idiopathic urinary retention: Can phenotyping improve outcome for patients: ICI-RS 2019?. Neurourol. Urodyn. 39(Suppl 3), S104-s112 (2020).","journal-title":"Neurourol. Urodyn."},{"issue":"3","key":"61910_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00192-020-04427-w","volume":"32","author":"Q He","year":"2021","unstructured":"He, Q. et al. Treatment for refractory overactive bladder: A systematic review and meta-analysis of sacral neuromodulation and onabotulinumtoxinA. Int. Urogynecol. J. 32(3), 477\u2013484 (2021).","journal-title":"Int. Urogynecol. J."},{"issue":"6","key":"61910_CR29","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.euf.2020.06.013","volume":"7","author":"M Abrar","year":"2021","unstructured":"Abrar, M. et al. Predictors of poor response and adverse events following botulinum toxin A for refractory idiopathic overactive bladder: A systematic review. Eur. Urol. Focus 7(6), 1448\u20131467 (2021).","journal-title":"Eur. Urol. Focus"},{"issue":"3","key":"61910_CR30","doi-asserted-by":"publisher","first-page":"351.e1","DOI":"10.1016\/j.jpurol.2022.02.007","volume":"18","author":"AP Lambregts","year":"2022","unstructured":"Lambregts, A. P. et al. Intravesical botulinum-A toxin in children with refractory non-neurogenic overactive bladder. J. Pediatr. Urol. 18(3), 351.e1-351.e8 (2022).","journal-title":"J. Pediatr. Urol."},{"key":"61910_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/ans.19309","author":"G He","year":"2024","unstructured":"He, G., Shen, N. & Feng, S. Botulinum toxin A for the treatment of neurogenic bladder in children: A systematic review and meta-analysis. ANZ J. Surg. https:\/\/doi.org\/10.1111\/ans.19309 (2024).","journal-title":"ANZ J. Surg."},{"issue":"2","key":"61910_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/bju.12669","volume":"115","author":"PP Smith","year":"2015","unstructured":"Smith, P. P., DeAngelis, A. & Simon, R. Evidence of increased centrally enhanced bladder compliance with ageing in a mouse model. BJU Int. 115(2), 322\u2013329 (2015).","journal-title":"BJU Int."},{"issue":"2","key":"61910_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","volume":"64","author":"C Chapple","year":"2013","unstructured":"Chapple, C. et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur. Urol. 64(2), 249\u2013256 (2013).","journal-title":"Eur. Urol."},{"issue":"12","key":"61910_CR34","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1016\/j.jpedsurg.2020.05.019","volume":"55","author":"C Hui","year":"2020","unstructured":"Hui, C. Safety and efficacy of trigonal BTX-A injections for children with neurological detrusor overactivity secondary to spinal cord injury. J. Pediatr. Surg. 55(12), 2736\u20132739 (2020).","journal-title":"J. Pediatr. Surg."},{"issue":"1","key":"61910_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/sc.2015.143","volume":"54","author":"C Hui","year":"2016","unstructured":"Hui, C. et al. Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity. Spinal Cord 54(1), 46\u201350 (2016).","journal-title":"Spinal Cord"},{"issue":"4","key":"61910_CR36","doi-asserted-by":"publisher","first-page":"520.e1","DOI":"10.1016\/j.jpurol.2021.02.020","volume":"17","author":"YO Danacioglu","year":"2021","unstructured":"Danacioglu, Y. O. et al. Factors predicting the success of intradetrusor onabotulinum toxin-A treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort. J. Pediatr. Urol. 17(4), 520.e1-520.e7 (2021).","journal-title":"J. Pediatr. Urol."},{"key":"61910_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051300","author":"C Pellegrino","year":"2023","unstructured":"Pellegrino, C. et al. Onabotulinum toxin A intradetrusor injections in children with neurogenic lower urinary tract dysfunction: Long-term histological effects on the bladder wall. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines11051300 (2023).","journal-title":"Biomedicines"},{"issue":"5","key":"61910_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.purol.2021.10.010","volume":"32","author":"FX Madec","year":"2022","unstructured":"Madec, F. X. et al. Repeated detrusor injection of botulinum toxin A for neurogenic bladder in children: A long term option?. Prog. Urol. 32(5), 319\u2013325 (2022).","journal-title":"Prog. Urol."},{"issue":"6","key":"61910_CR39","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/nau.24962","volume":"41","author":"DK Bowen","year":"2022","unstructured":"Bowen, D. K. et al. Botulinum toxin in patients at-risk for bladder augmentation: Durable impact or kicking the can?. Neurourol. Urodyn. 41(6), 1406\u20131413 (2022).","journal-title":"Neurourol. Urodyn."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61910-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61910-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61910-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:47:00Z","timestamp":1791190020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61910-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61910"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61910-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Number: 2020-KY-191). All guardians of the children were informed of the possible adverse reactions after BTX-A injection, and written informed consent was obtained from all guardians before treatment. All research involving human research participants has been performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All Authors have seen and approved the manuscript and consent to publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30899"}}